This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Trusted global supplier of high-purity heparin sodium, enoxaparin, nadroparin, and dalteparin. Bovine and porcine sources. Complete heparin industrial chain from crude to finished injections.
A leading Chinese enterprise in the field of heparin series pharmaceuticals with a complete industrial chain from crude heparin to low molecular weight heparin injections.
Founded in September 2000 and listed on the Shenzhen Stock Exchange (stock code: 300255) on August 19, 2011, HBcsbio is a key high-tech enterprise integrating R&D, production, sales, and international trade.
The company operates four production bases, nine subsidiaries, two overseas companies, and two joint ventures, employing over 1,300 professionals. It is a leader in domestic heparin product manufacturing.
2000
Founded
1,300+
Employees
11
Patents
$68M
Exports (2019)
Quality of survival, management for efficiency, integrity and reputation, innovation and development.
Premier certified producer of high-quality, cost-effective heparin APIs and formulations with global regulatory approvals.
Integrated production from crude heparin to finished low molecular weight heparin injections with full process control.
High-purity APIs, injections, and specialty products for pharmaceutical and medical use.
High-purity anticoagulant API derived from porcine intestinal mucosa. Suitable for injection formulations and clinical use.
Bovine-derived heparin API. Ideal for halal-compliant pharmaceutical applications and global markets.
Low molecular weight heparin (LMWH) injection for prophylaxis and treatment of venous thromboembolism.
LMWH used in the prevention of deep vein thrombosis and pulmonary embolism, especially post-surgery.
Another LMWH formulation for anticoagulant therapy with predictable pharmacokinetics and dosing.
Raw heparin extracted from animal sources, serving as the starting material for further purification and API production.
Active pharmaceutical ingredient for enoxaparin-based injectables. High purity and consistent quality.
Edible animal casings used in food processing, particularly for sausages and specialty meat products.
Regulatory approvals for APIs and finished formulations in multiple international markets.
Focus on R&D and new drug development, including joint ventures with international partners.
From crude heparin to finished injections — full control over quality and supply chain.
Over $68 million in exports in 2019, serving pharmaceutical partners worldwide.
2000
Founded
300255
Stock Code
4
Production Bases
9+
Subsidiaries
Porcine heparin is derived from pig intestinal mucosa and is the most common source. Bovine heparin comes from cow lungs or intestines and is used in halal-compliant products.
Yes, HBcsbio has regulatory approvals for APIs and finished formulations in multiple countries, including dossiers submitted to major regulatory agencies.
Yes, we support OEM and ODM partnerships for pharmaceutical companies seeking custom heparin-based products.
LMWHs like enoxaparin, nadroparin, and dalteparin are derived from unfractionated heparin but have more predictable anticoagulant effects and longer half-lives.
For inquiries about products, partnerships, or regulatory information, visit the official website.
Tel: 86-311-89199752
Email: fdf@hbcsbio.com
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact support@fobcompany.info via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系support@fobcompany.info 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact support@fobcompany.info
如果您是其他域名合作 也请联系support@fobcompany.info